Robert Tulloh

University of Bristol

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Paul Clift

Honorary Senior Clinical Lecturer

University of Birmingham

UNITED KINGDOM

View details

Andrew Constantine

University Hospitals Birmingham NHS Foundation Trust

UNITED KINGDOM

View details

Jason Johnson

University of Bristol

UNITED KINGDOM

View details

veronica swallow

Professor of Child & Family Nursing & Healthcare

Sheffield Hallam University Sheffield Business School

UNITED KINGDOM

View details

Mandy Wan

King’s College London

UNITED KINGDOM

View details

Konstantinos Dimopoulos

Professor of Practice in ACHD and PH

Imperial College London

UNITED KINGDOM

View details

Alexander Gall

Texas Heart Institute

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Tulloh

Research Interests

Explore related searches

Contact this professor

Articles (16)

Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol

Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom

Corticosteroids for the treatment of Kawasaki disease in children.

Pulmonary arterial hypertension in adults with congenital heart disease: markers of disease severity, management of advanced heart failure and transplantation

Does Maintenance of Pulmonary Blood Flow Pulsatility at the Time of the Fontan Operation Improve Hemodynamic Outcome in Functionally Univentricular Hearts?

Quantitative evaluation and comparison of coronary artery characteristics by 3D coronary volume reconstruction

Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion.

Design and Development Armband Vital Sign Monitor for Health-Care Monitoring.

Inflammatory markers in Eisenmenger syndrome and their association with clinical outcomes. A cross-sectional comparative study.

NF-κB inhibition prevents acute shear stress-induced inflammation in the saphenous vein graft endothelium

Advanced therapies in complex congenital heart disease

Strategies for the management of pulmonary arterial hypertension in patients with congenital heart disease

Should we use steroids as primary therapy for Kawasaki disease?

Intermittent antegrade warm-blood versus cold-blood cardioplegia in children undergoing open heart surgery

Age over 35 years is associated with increased mortality after pulmonary valve replacement in repaired tetralogy of Fallot: results from the UK National Congenital Heart Disease Audit database

Outcomes following aortic valve procedures in 201 complex congenital heart disease cases—results from the UK National Audit

Collaborators (7)

Paul Clift

Andrew Constantine

Jason Johnson

veronica swallow

Mandy Wan

Konstantinos Dimopoulos

Alexander Gall

Make your next move.